<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">



<DIV style="font-size: 10pt">
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>


<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P align="center" style="font-size: 18pt"><B>FORM 8-K</B>

<P align="center" style="font-size: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P align="center" style="font-size: 10pt"><B>Date of Report (Date of earliest event reported): November 19, 2008</B>

<P align="center">

<P align="center" style="font-size: 24pt"><B>EBIX, INC.<BR></B>
<FONT style="font-size: 10pt">(Exact name of registrant as specified in its charter)
</FONT>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="32%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>Delaware</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>0-15946</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>77-0021975</B></TD>
</TR>
<TR valign="top">
    <TD>(State or other Jurisdiction of Incorporation)</TD>
    <TD>&nbsp;</TD>
    <TD>(Commission File Number)</TD>
    <TD>&nbsp;</TD>
    <TD>(IRS Employer Identification No.)</TD>
</TR>
</TABLE>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="49%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>5 Concourse Parkway, Suite 3200, Atlanta, Georgia<BR></B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>30328</B></TD>
</TR>
<TR valign="top">
    <TD>(Address of Principal Executive Offices)</TD>
    <TD>&nbsp;</TD>
    <TD>(Zip Code)</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt">Registrant&#146;s telephone number, including area code: <B>(678) 281-2020</B>


<TABLE border="0" width="30%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="100%">&nbsp;</TD>
</TR>
<TR>
    <TD nowrap style="border-bottom: 1px solid #000000"><B>&nbsp;</B></TD>
</TR>
<TR>
    <TD nowrap>(Former name or former address if changed since last report.)</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:

<P align="left" style="font-size: 10pt">
<FONT face="Wingdings">&#254;</FONT> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<P>
<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>

</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="left" style="font-size: 10pt"><B>Item&nbsp;8.01: Other Events.</B>


<P align="left" style="font-size: 10pt; text-indent: 4%">On November&nbsp;19, 2008, the registrant, Ebix, Inc. (NASDAQ: EBIX), announced via a press release that it had decided
to extend until December&nbsp;31, 2008, its all stock offer at $0.85 per share in respect to a business combination
transaction with HealthAxis, Inc. (&#147;HealthAxis&#148;) (NASDAQ: HAXS).&nbsp;The equivalent consideration to be provided will be
payable in the form of shares of Ebix common stock valued at the 15-day average closing price preceding the date that
the business combination is consummated. Ebix will allow existing HealthAxis warrant holders to convert their warrants to into Ebix
common stock when Ebix&#146;s stock price increases proportionately by the same percentage as would have been required of HealthAxis&#146;s common stock under the terms of HealthAxis warrants.


<P align="left" style="font-size: 10pt; text-indent: 4%">A copy of this press release is attached as Exhibit&nbsp;99.1 and is incorporated herein by reference. A copy of Ebix&#146;s
letter to the HealthAxis board of directors is attached as Exhibit&nbsp;99.2 and is incorporated herein by reference.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;9.01:&nbsp; Exhibits.</B>


<P align="left" style="font-size: 10pt; text-indent: 4%">The following exhibits are being furnished with this report pursuant to Item&nbsp;8.01of this Form&nbsp;8-K:

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="6%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="91%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit&nbsp;No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press Release dated November&nbsp;19, 2008 re: Ebix&#146;s Extension of its Offer to Purchase HealthAxis.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Letter dated November&nbsp;19, 2008 from Ebix to HealthAxis&#146;s Board of Directors.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">



<P align="center" style="font-size: 10pt"><U><B>SIGNATURES</B></U>



<P align="left" style="font-size: 10pt; text-indent: 4%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.



<P align="left" style="margin-left:46%; font-size: 10pt">EBIX, INC.



<P align="left" style="margin-left:46%; font-size: 10pt">By: <U><B>/</B>s/ Robert F. Kerris&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
Robert Kerris<BR>
Chief Financial Officer<BR>
and Corporate Secretary<BR>


<P align="left" style="font-size: 10pt">November&nbsp;20, 2008

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="center" style="font-size: 10pt"><B>EXHIBIT INDEX</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="6%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="91%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit&nbsp;No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press Release dated November&nbsp;19, 2008 re: Ebix&#146;s Extension of its Offer to Purchase HealthAxis.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Letter dated November&nbsp;19, 2008 from Ebix to HealthAxis&#146;s Board of Directors.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">4




</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c77592e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 9638}]
{"company-data": {"conformed-name": "EBIX INC", "cik": "0000814549", "assigned-sic": "7373", "irs-number": "770021975", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-15946", "film-number": "081203921"}, "business-address": {"street1": "FIVE CONCOURSE PARKWAY", "street2": "SUITE 3200", "city": "ATLANTA", "state": "2Q", "zip": "30328", "phone": "678-281-2020"}, "mail-address": {"street1": "FIVE CONCOURSE PARKWAY", "street2": "SUITE 3200", "city": "ATLANTA", "state": "2Q", "zip": "30328"}, "former-company": [{"former-conformed-name": "EBIX COM INC", "date-changed": "19991115"}, {"former-conformed-name": "DELPHI INFORMATION SYSTEMS INC /DE/", "date-changed": "19920703"}]}
Filed by Bowne Pure Compliance
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 19, 2008
EBIX, INC.
(Exact name of registrant as specified in its charter)
Delaware
0-15946
77-0021975
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
5 Concourse Parkway, Suite 3200, Atlanta, Georgia
30328
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code:
(678) 281-2020
(Former name or former address if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
þ
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01: Other Events.
On November 19, 2008, the registrant, Ebix, Inc. (NASDAQ: EBIX), announced via a press release that it had decided
to extend until December 31, 2008, its all stock offer at $0.85 per share in respect to a business combination
transaction with HealthAxis, Inc. ("HealthAxis") (NASDAQ: HAXS). The equivalent consideration to be provided will be
payable in the form of shares of Ebix common stock valued at the 15-day average closing price preceding the date that
the business combination is consummated. Ebix will allow existing HealthAxis warrant holders to convert their warrants to into Ebix
common stock when Ebix's stock price increases proportionately by the same percentage as would have been required of HealthAxis's common stock under the terms of HealthAxis warrants.
A copy of this press release is attached as Exhibit 99.1 and is incorporated herein by reference. A copy of Ebix's
letter to the HealthAxis board of directors is attached as Exhibit 99.2 and is incorporated herein by reference.
Item 9.01:  Exhibits.
The following exhibits are being furnished with this report pursuant to Item 8.01of this Form 8-K:
Exhibit No.
Description
99.1
Press Release dated November 19, 2008 re: Ebix's Extension of its Offer to Purchase HealthAxis.
99.2
Letter dated November 19, 2008 from Ebix to HealthAxis's Board of Directors.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
EBIX, INC.
By:
/
s/ Robert F. Kerris
Robert Kerris
Chief Financial Officer
and Corporate Secretary
November 20, 2008
EXHIBIT INDEX
Exhibit No.
Description
99.1
Press Release dated November 19, 2008 re: Ebix's Extension of its Offer to Purchase HealthAxis.
99.2
Letter dated November 19, 2008 from Ebix to HealthAxis's Board of Directors.